論文目録

Shibasaki Y., Nishiue T., Masaki H., et al: Impact of angiotensin II receptor antagonist ,Losartan,on myocardial fibrosis in patients with end-stage renal disease: Assessment by ultrasonic integrated backscatter and biochemical markers. Hypertens Res. 2005;28: No.10:787-795.


Shibasaki Y., Masaki H., Nishiue T., et al: Angiotensin II type 1 receptor antagonist, Losartan causes regression of left ventricular hypertrophy in end stage renal disease. Nephron 2002;90:256-261


Shibasaki Y., Mori Y., Tsutsumi Y., et al: Differential kinetics of circulating Angiotensin IV and II after treatment with angiotensin II type 1 receptor antagonist and their plasma levels in patients with chronic renal failure .Clin Nephrol. 1999;51: 83-91.


柴崎泰延,西上尚志,正木浩哉他: 透析患者におけるARBの心肥大・線維化抑制効果. 日本臨床60:1992-1998,2002


柴崎泰延,森 泰清,西川光重他: 糖尿病性腎症患者への透析導入の根拠と実施時のポイントとは何か. 透析strategy No5:9-12,2002


柴崎泰延,西上尚志,正木浩哉他: 透析心におけるAng II 1型受容体拮抗薬の心肥大退縮、Therapeutic Research.22(6):1316-1320,2001